ExeVir develops novel antibody therapies capable of preventing and treating current public health threats and responding to future outbreaks with speed and agility.
ExeVir develops novel antibody therapies capable of preventing and treating current public health threats and responding to future outbreaks with speed and agility.
Better together
MEDVIA and flanders.bio have joined forces to become Biovia
Biovia is the new name of the health innovation cluster formed by the merger of MEDVIA and flanders.bio. With a united voice, we will champion the entire healthtech and biotech ecosystem on the regional, federal and European stage.
Biovia reflects a One Health vision: a holistic approach that recognizes the interdependence of human and planetary health. Together with our 400+ members, we are forging a path to a resilient health innovation ecosystem in Flanders.